4//SEC Filing
Zygmont Chester Stanley III 4
Accession 0000950170-25-020104
CIK 0001810560other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 6:05 PM ET
Size
6.7 KB
Accession
0000950170-25-020104
Insider Transaction Report
Form 4
Zygmont Chester Stanley III
Chief Financial Officer
Transactions
- Award
Common Stock
2025-02-11$3.87/sh+15,048$58,236→ 15,076 total(indirect: By Trust)
Holdings
- 28(indirect: By Trust)
Common Stock
- 13(indirect: By LLC)
Common Stock
Footnotes (3)
- [F1]Restricted Stock Grant under the 2021 Equity Incentive Plan. Vests 100% on date of grant.
- [F2]Shares are held by The Zygmont Family Trust Dated October 25, 2016, with respect to which Chester S Zygmont III is a trustee.
- [F3]Shares are held by Czeslaw Capital Fund, LLC. Chester S Zygmont III is the sole manager of Czeslaw Capital Fund, LLC.
Documents
Issuer
REVELATION BIOSCIENCES, INC.
CIK 0001810560
Entity typeother
Related Parties
1- filerCIK 0001900657
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 6:05 PM ET
- Size
- 6.7 KB